AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,663,000 | +192.3% | 56,275 | +369.9% | 0.09% | +176.5% |
| Q1 2019 | $569,000 | +41.5% | 11,975 | +7.5% | 0.03% | +30.8% |
| Q4 2018 | $402,000 | -42.9% | 11,137 | -16.9% | 0.03% | -29.7% |
| Q2 2017 | $704,000 | -56.2% | 13,400 | -62.3% | 0.04% | -50.0% |
| Q1 2017 | $1,609,000 | +439.9% | 35,500 | +349.4% | 0.07% | -22.9% |
| Q3 2016 | $298,000 | -54.0% | 7,900 | -78.6% | 0.10% | +200.0% |
| Q2 2016 | $648,000 | -69.0% | 36,867 | -78.6% | 0.03% | -66.0% |
| Q1 2016 | $2,091,000 | +13.2% | 172,032 | +126.7% | 0.09% | +6.8% |
| Q4 2015 | $1,847,000 | -38.2% | 75,887 | -55.2% | 0.09% | -12.0% |
| Q2 2015 | $2,990,000 | +433.0% | 169,438 | +781.3% | 0.10% | +376.2% |
| Q4 2014 | $561,000 | – | 19,226 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |